RESÚMENES OCTUBRE 2004

.

Other Neuropsychiatric Disorders

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease

Dominic M. Walsh and Dennis J. Selkoe

Neuron. Volume 44, Issue 1, 30 September 2004, Pages 181-193

 

Use of reboxetine in bulimia nervosa
Secondo Fassino, Giovanni Abbate Daga, Sonia Boggio, Lorenzo Garzaro and Andrea Pierò

Journal of Psychopharmacology. Volume 18 Issue 03 - Publication Date: 09/2004

Individual Growth Curve Analysis Illuminates Stability and Change in Personality Disorder Features. The Longitudinal Study of Personality Disorders

Mark F. Lenzenweger, Matthew D. Johnson, John B. Willett

Arch Gen Psychiatry. 2004;61:1015-1024

 

Personality disorders in the community: Results from the Australian National Survey of Mental Health and Well-Being Part III. Relationships between specific type of personality disorder, Axis 1 mental disorders and physical conditions with disability and health consultations

Henry J. Jackson and Philip M. Burgess

Social Psychiatry and Psychiatric Epidemiology. Volume 39, Number 10;  October 2004: 765 - 776

 

Improved mood states with lamotrigine in patients with epilepsy.
Cramer JA, Hammer AE, Kustra RP.

Epilepsy Behav. 2004 Oct;5(5):702-7

 

Cognitive dysfunction and dementia in Parkinson's disease

J. L. W. Bosboom, D. Stoffers and E. Ch. Wolters

Journal of Neural Transmission 2004; Volume 111, Numbers 10-11: 1303 - 1315

 

Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease

D. Merims, H. Shabtai, A. D. Korczyn, C. Peretz, N. Weizman and N. Giladi

Journal of Neural Transmission 2004; Volume 111, Numbers 10-11: 1447 - 1453

 

Functional imaging in Tourette's syndrome

J. R. Adams, A. R. Troiano and D. B. Calne

Journal of Neural Transmission 2004; Volume 111, Numbers 10-11: 1495 - 1506

 

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, et al.

Arthritis Rheum 2004;50(9):2974-2984

 

Cerebral White Matter Lesions and the Risk of Dementia

Niels D. Prins, Ewoud J. van Dijk, Tom den Heijer, Sarah E. Vermeer, Peter J. Koudstaal, Matthijs Oudkerk, Albert Hofman, Monique M. B. Breteler

Arch Neurol. 2004;61:1531-1534

 

Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Bonelli, Raphael M.; Hodl, Anna K.; Hofmann, Peter; Kapfhammer, Hans-Peter

International Clinical Psychopharmacology. 19(6):337-342, November 2004.

Clinical Perspective of Attention-Deficit/Hyperactivity Disorder Into Adulthood

Timothy E. Wilens, and William Dodson

J Clin Psychiatry 2004;65:1301-1313

 

Behavioral and Psychological Symptomsin Patients With Dementia as a Targetfor Pharmacotherapy With Risperidone

Jonathan Rabinowitz, Ira R. Katz, Peter Paul De Deyn, Henry Brodaty, Andrew Greenspan, and Michael Davidson

J Clin Psychiatry 2004;65:1329-1334

 

 

Trends in adolescent suicide mortality in the WHO European Region

Ellenor Mittendorfer Rutz and Danuta Wasserman

European Child & Adolescent Psychiatry 2004; Volume 13, Number 5: 321 - 331

 

Clinical, Cognitive, and Neurophysiologic Correlates of Short-Term Treatment with Carbamazepine, Oxcarbazepine, and Levetiracetam in Healthy Volunteers

Oriano Mecarelli, Edoardo Vicenzini, Patrizia Pulitano, Nicola Vanacore, Francesco Saverio Romolo, Vittorio Di Piero, Gian Luigi Lenzi, Neri Accornero

The Annals of Pharmacotherapy: Vol. 38, No. 11, pp. 1816-1822

 

Evaluation of Lamotrigine Toxicity Reported to Poison Centers

Amanda L Lofton, Wendy Klein-Schwartz

The Annals of Pharmacotherapy: Vol. 38, No. 11, pp. 1811-1815

 

Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study

Russell Viner, Matthew Hotopf

BMJ  2004;329:941 (23 October, 2004)

 

Poor social integration and suicide: fact or artifact? A case-control study

P. R. DUBERSTEIN, Y. CONWELL, K. R. CONNER, S. EBERLY, J. S. EVINGER and E. D. CAINE 

Psychological Medicine (2004), 34:7:1331-1337

 

Available pharmacological treatments for anorexia nervosa

Pauline S Powers; Carlos Santana

Expert Opinion on Pharmacotherapy. 2004, vol. 5, no. 11, pp. 2287 - 2292

 

The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease

Bruno P Imbimbo

Expert Opinion on Investigational Drugs. 2004, vol. 13, no. 11, pp. 1469 - 1481

 

Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions

Bridget F. Grant, Deborah S. Hasin, Frederick S. Stinson, Deborah A. Dawson, S. Patricia Chou, W. June Ruan and Boji Huang

Journal of Psychiatric Research. Volume 39, Issue 1, January 2005, Pages 1-9
.

Regresar a RESÚMENES OCTUBRE 2004